X0708 D LIVE 0001469443 Arcadia Biosciences, Inc. 5956 SHERRY LANE SUITE 2000 DALLAS TX TEXAS 75225 214-974-8921 DELAWARE None None Corporation true Thomas J. Schaefer 5950 Sherry Lane Suite 2000 Dallas TX TEXAS 75225 Executive Officer Director Kevin Comcowich 5950 Sherry Lane Suite 2000 Dallas TX TEXAS 75225 Director Amy Yoder 5950 Sherry Lane Suite 200 Dallas TX TEXAS 75225 Director Lilian Shackelford Murray 5950 Sherry Lane Suite 2000 Dallas TX TEXAS 75225 Director Gregory D Waller 5950 Sherry Lane Suite 200 Dallas TX TEXAS 75225 Director Other Technology Decline to Disclose 06b false 2026-06-12 false true true true false 0 H.C. Wainwright & Co, LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 NY NEW YORK false 11417964 3999613 7418351 Includes gross proceeds received from issuance of pre-funded warrants & preferred investment options. Offering also reflects the aggregate exercise price of pre-funded warrants, preferred investment options and placement agent investment options issued. false 5 395000 0 In addition to cash fee, the company paid certain expenses of $75,000 and issued placement agent preferred investment options to purchase up to 271,845 shares of common stock at exercise price $1.2875 per share. 0 false Arcadia Biosciences, Inc. Thomas J. Schaefer Thomas J. Schaefer CEO 2026-06-18